News

MEDIA CONTACT

Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, Oct. 31, 2017

Gainesville, Fla. (Oct. 25, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that,…

View Story

Exactech Enters Definitive Agreement with TPG Capital to Go Private

Leading Healthcare Investor Provides Company with Strategic Growth Capital Exactech Shareholders To Receive $42.00 Per Share In Cash Transaction Values Exactech at $625 Million Represents a Premium of Approximately 31%…

View Story

Exactech Comments on Impact of Hurricanes Irma and Harvey. Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call

GAINESVILLE, Fla. (October 12, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it…

View Story

Exactech To Present to Investors at Baird 2017 Global Healthcare Conference

Gainesville, Fla. – September 5, 2017 — Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will…

View Story

Exactech’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)

GAINESVILLE, Fla. (Aug. 21, 2017) – Exactech (Nasdaq:EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that the new…

View Story

Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue; Q2 Net Income $4.8 Million; Diluted EPS $0.33

Gainesville, Fla. (July 27, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that…

View Story

Media contact

Nancy Walsh
Senior Marketing Communications Director
media@exac.com
352-377-1140

Courtney Adkins
Marketing Communications Director
media@exac.com
352-377-1140

News

Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, Oct. 31, 2017

Exactech Enters Definitive Agreement with TPG Capital to Go Private

Exactech Comments on Impact of Hurricanes Irma and Harvey. Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call

Exactech To Present to Investors at Baird 2017 Global Healthcare Conference

Exactech’s Truliant® Knee System Instrumentation Honored with International Design Excellence Award (IDEA®)

Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue; Q2 Net Income $4.8 Million; Diluted EPS $0.33

Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call

Exactech Introduces New Computer-Assisted Software Application for Simplified Guidance in Total Knee Replacement

Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems

Alteon® HA Femoral Hip Stem Rounds Out Big Week of First Surgeries for Exactech

Media contact

Company Info

Compliance

Learn More

News

Sign up to receive email alerts

Media contact

Company Info

Compliance

Learn More